Essays on Global Market Analysis of an MNE - Roche Pharmaceutical Company Case Study

Download full paperFile format: .doc, available for editing

The paper 'Global Market Analysis of an MNE - Roche Pharmaceutical Company " is a good example of a marketing case study. Multinational Enterprises (MNEs) are main actors in global business, according to Bartlett and Ghoshal (2000, p. 14), an MNE is a firm that has direct foreign investment (FDI) and it is involved in actively managing the firm in a foreign country. This paper analyses factors leading to an MNE engaging in foreign direct investment. The MNE under analysis is Roche, a leading pharmaceutical company with a global outlook and the country of entry in Indonesia.

There are many factors that affect business in Indonesia and that may serve as attracting factors for Roche to enter the market. This will be discussed in detail by analyzing Indonesia and the ASEAN region as a whole. SWOT analysis will be used to analyze MNE firm and recommendation for strategies that the firm can employ in expanding to Indonesia. The analysis will help in identifying the entry mode that can be adopted by Roche in entering Indonesia, the analysis will be aided by relevant theories that influence the mode of FDI. MNE Analysis: ROCHE Roche is a multinational enterprise dealing with pharmaceutical products; the company is headquartered in Basel, Switzerland and has been in operation for over a century.

It produces drugs for autoimmune diseases, virology, metabolic disorders, central nervous system diseases and it is a world leader in in-vitro diagnostics and cancer drugs (Hummer 2005, p. 12). SWOT analysis of Roche Strengths In 2009 Roche completed the acquisition of Genentech for $ 4.6 billion (Hummer 2005, p. 13). Therefore, the company got access to the portfolio of oncology which strategically aligned the company to revenue growth and increased its competitive advantage in the oncology market.

As a result, the company share in oncology market augmented to 30.4% and shields the company from exposure to non-patents in future (Hearing 2005, p. 2). Roche holds a revenue of over 47.7 billion Swiss Francs. In order to ensure quality and maintain its competitiveness across the globe, Roche has 80,000 employees who include 25,000 scientists (Hummer 2005, p. 17). The division of diagnostics and pharmacy work under one command which is a strategy in ensuring an efficient decision-making process and ensures that the products are analyzed at every step of production hence, ensuring quality. Weakness Roche holds the patent to drugs such as Tamiflu, however, the drug is massively produced in the developing countries and there are no efficient distribution channels which have made the company not to fairly utilize its patents (Hummer 2005, p.

22). In addition, Roche experiences a high cost of production which lowers its price competitiveness in the global market. Opportunities Indonesia presents a great opportunity to Roche; the country has been recording economic growth and has a population of over 250 million making a ready market for Roche.

High capital base and production of pharmaceuticals based on research will be key entry factor that Roche has capability in. According to Hearing (2005, p. 3), Roche diagnostic system is one of the best and has made it to be a competitive edge in the international market. Threats Roche faces stiff competition from other world leaders who already have distribution channels in Indonesia such as Aboot, Sanofi Aventis and Siemens. The market share in the pharmaceutical business is also limited due to patent products and generic drugs.

References

Aguera, R.2009. Going it alone: Strategy into foreign markets. Available at https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=6&ved=0CEcQFjAF&url=https%3A%2F%2Fwww.business.illinois.edu%2Faguilera%2FTeaching%2FGS%2520entry%2520mode%2520Freixenet.ppt&ei=n1mIVL2tJInkarfngJAJ&usg=AFQjCNEpncsiStogNvOQMuzoXsdYa3ZJEg&sig2=q2iu_yA7b6nuaAaCyQEFcQ&bvm=bv.81456516,d.d2s&cad=rja

[Accessed on 10th December 2014]

ASEAN. 2014. Investing in ASEAN 2013-2014; Available at, http://www.usasean.org/system/files/downloads/Investing-in-ASEAN-2013-14.pdf

[Accessed on 10th December 2014]

Bartlett, C and Ghoshal, S, 2001 (ed). Managing across borders: the transnational solution, Harvard Business School Press, Boston, MA, pp. 12-19.

Brouthers, K. D. and Brouthers, L. E. 2000. Acquisition or Greenfield Start-up? Institutional, Cultural and Transaction Cost Influences. Strategic Management Journal 21 (1), pp. 89- 97

Buckley, P. and Hashai N. 2009. Formalizing internationalization in the eclectic paradigm. Journal of International Business Studies 40(1, pp.58–70.

Etienne, E. 2009. International Trade: An Explanation of Today’s Foreign Direct

Investment into Emerging Economies. Mercer University, USA: Stetson School of Business and Economics, p. 1-8.

Gray, H. and Peter. 2003. Extending the Eclectic Paradigm in International Business: Essays in Honor of John Dunning. Edward Elgar Publishing, pp. 3-9.

Foss, N and Pedersen, T. 2004 Organizing knowledge processes in the multinational corporation: an introduction. Journal of International Business Studies, 35, pp.340–349.

Hadiwinata, P. Arsono, H and Rekan, H. 2009. Doing business in Indonesia. PKF International Limited, pp. 2-26.

Hansen, H. and Rand, J. 2006. On the Causal Links Between FDI and Growth in Developing Countries. The World Economy, 29 (1), pp.21-41.

Hashai N, Buckley P. 2014. Is competitive advantage a necessary condition for the emergence of multinational enterprise? Global Strategy Journal 4(1), pp. 2-17.

Horaguchi, H. and Toyne, B. 2000. Setting the Record Straight: Hymer, Internalization Theory and Transaction Cost Economics. Journal of International Business Studies, 21(1), pp.487-494.

Hummer, F. B. (2005). Market dynamics in health care industry: the relevance of Roche strategy in current market. Road Shadow Zurich, pp. 12-24

Hearing, R. 2005. Roche Finance report 2010. Hoffman La Roche Ltd, p. 1-5.

Johnson, A. 2006. The Effects of FDI Inflows on Host Country Economic Growth. CESIS Working Paper Series. Sweden: Royal Institute of Technology, pp. 2-11.

O'Brien, D. (2001). Integrating Corporate Social Responsibility with Competitive Strategy. Center for Corporate Citizenship, pp. 1-4.

Porter, M. 2000. Location, Competition, and Economic Development: Local Clusters in a Global Economy. Economic Development Quarterly, 14, (1), pp. 2-33.

Download full paperFile format: .doc, available for editing
Contact Us